297 related articles for article (PubMed ID: 28381469)
1. Phase I Clinical Trial of Autologous Stem Cell-Sheet Transplantation Therapy for Treating Cardiomyopathy.
Miyagawa S; Domae K; Yoshikawa Y; Fukushima S; Nakamura T; Saito A; Sakata Y; Hamada S; Toda K; Pak K; Takeuchi M; Sawa Y
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28381469
[TBL] [Abstract][Full Text] [Related]
2. Clinical Outcomes of Autologous Stem Cell-Patch Implantation for Patients With Heart Failure With Nonischemic Dilated Cardiomyopathy.
Domae K; Miyagawa S; Yoshikawa Y; Fukushima S; Hata H; Saito S; Kainuma S; Kashiyama N; Iseoka H; Ito E; Harada A; Takeda M; Sakata Y; Toda K; Pak K; Yamada T; Sawa Y
J Am Heart Assoc; 2021 Jul; 10(13):e008649. PubMed ID: 34212772
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
Tompkins BA; Rieger AC; Florea V; Banerjee MN; Natsumeda M; Nigh ED; Landin AM; Rodriguez GM; Hatzistergos KE; Schulman IH; Hare JM
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30005555
[TBL] [Abstract][Full Text] [Related]
4. Effects of transendocardial CD34+ cell transplantation in patients with ischemic cardiomyopathy.
Poglajen G; Sever M; Cukjati M; Cernelc P; Knezevic I; Zemljic G; Haddad F; Wu JC; Vrtovec B
Circ Cardiovasc Interv; 2014 Aug; 7(4):552-9. PubMed ID: 25097199
[TBL] [Abstract][Full Text] [Related]
5. Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy.
Vrtovec B; Poglajen G; Lezaic L; Sever M; Socan A; Domanovic D; Cernelc P; Torre-Amione G; Haddad F; Wu JC
Circulation; 2013 Sep; 128(11 Suppl 1):S42-9. PubMed ID: 24030420
[TBL] [Abstract][Full Text] [Related]
6. [A prospective, randomized, controlled trial of autologous mesenchymal stem cells transplantation for dilated cardiomyopathy].
Wang JA; Xie XJ; He H; Sun Y; Jiang J; Luo RH; Fan YQ; Dong L
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Feb; 34(2):107-10. PubMed ID: 16626573
[TBL] [Abstract][Full Text] [Related]
7. Safety and outcomes analysis: transcatheter implantation of autologous angiogenic cell precursors for the treatment of cardiomyopathy.
Schubart JR; Zare A; Fernandez-de-Castro RM; Figueroa HR; Sarel I; Tuchman K; Esposito K; Henderson FC; von Schwarz E
Stem Cell Res Ther; 2023 Oct; 14(1):308. PubMed ID: 37880753
[TBL] [Abstract][Full Text] [Related]
8. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.
Hare JM; Fishman JE; Gerstenblith G; DiFede Velazquez DL; Zambrano JP; Suncion VY; Tracy M; Ghersin E; Johnston PV; Brinker JA; Breton E; Davis-Sproul J; Schulman IH; Byrnes J; Mendizabal AM; Lowery MH; Rouy D; Altman P; Wong Po Foo C; Ruiz P; Amador A; Da Silva J; McNiece IK; Heldman AW; George R; Lardo A
JAMA; 2012 Dec; 308(22):2369-79. PubMed ID: 23117550
[TBL] [Abstract][Full Text] [Related]
9. Myocardial regenerative therapy using a scaffold-free skeletal-muscle-derived cell sheet in patients with dilated cardiomyopathy even under a left ventricular assist device: a safety and feasibility study.
Yoshikawa Y; Miyagawa S; Toda K; Saito A; Sakata Y; Sawa Y
Surg Today; 2018 Feb; 48(2):200-210. PubMed ID: 28821963
[TBL] [Abstract][Full Text] [Related]
10. Effects of stem cells on non-ischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials.
Xia L; Zeng L; Pan J; Ding Y
Cytotherapy; 2020 Dec; 22(12):699-711. PubMed ID: 32893120
[TBL] [Abstract][Full Text] [Related]
11. Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study).
Martino H; Brofman P; Greco O; Bueno R; Bodanese L; Clausell N; Maldonado JA; Mill J; Braile D; Moraes J; Silva S; Bozza A; Santos B; Campos de Carvalho A;
Eur Heart J; 2015 Nov; 36(42):2898-904. PubMed ID: 26392433
[TBL] [Abstract][Full Text] [Related]
12. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
Vrtovec B; Poglajen G; Lezaic L; Sever M; Domanovic D; Cernelc P; Socan A; Schrepfer S; Torre-Amione G; Haddad F; Wu JC
Circ Res; 2013 Jan; 112(1):165-73. PubMed ID: 23065358
[TBL] [Abstract][Full Text] [Related]
13. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy.
Fischer-Rasokat U; Assmus B; Seeger FH; Honold J; Leistner D; Fichtlscherer S; Schächinger V; Tonn T; Martin H; Dimmeler S; Zeiher AM
Circ Heart Fail; 2009 Sep; 2(5):417-23. PubMed ID: 19808371
[TBL] [Abstract][Full Text] [Related]
14. Effects of Repetitive Transendocardial CD34
Vrtovec B; Poglajen G; Sever M; Zemljic G; Frljak S; Cerar A; Cukjati M; Jaklic M; Cernelc P; Haddad F; Wu JC
Circ Res; 2018 Jul; 123(3):389-396. PubMed ID: 29880546
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial.
Hamshere S; Arnous S; Choudhury T; Choudry F; Mozid A; Yeo C; Barrett C; Saunders N; Gulati A; Knight C; Locca D; Davies C; Cowie MR; Prasad S; Parmar M; Agrawal S; Jones D; Martin J; McKenna W; Mathur A
Eur Heart J; 2015 Nov; 36(44):3061-9. PubMed ID: 26333366
[TBL] [Abstract][Full Text] [Related]
16. Autologous transplantation of bone marrow mononuclear stem cells by mini-thoracotomy in dilated cardiomyopathy: technique and early results.
Kalil RA; Ott D; Sant'Anna R; Dias E; Marques-Pereira JP; Delgado-Cañedo A; Nardi NB; Sant'Anna JR; Prates PR; Nesralla I
Sao Paulo Med J; 2008 Mar; 126(2):75-81. PubMed ID: 18553028
[TBL] [Abstract][Full Text] [Related]
17. Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial.
Butler J; Epstein SE; Greene SJ; Quyyumi AA; Sikora S; Kim RJ; Anderson AS; Wilcox JE; Tankovich NI; Lipinski MJ; Ko YA; Margulies KB; Cole RT; Skopicki HA; Gheorghiade M
Circ Res; 2017 Jan; 120(2):332-340. PubMed ID: 27856497
[TBL] [Abstract][Full Text] [Related]
18. Beneficial hemodynamic and clinical effects of surgical ventricular restoration in patients with ischemic dilated cardiomyopathy.
Tulner SA; Bax JJ; Bleeker GB; Steendijk P; Klautz RJ; Holman ER; Schalij MJ; Dion RA; van der Wall EE
Ann Thorac Surg; 2006 Nov; 82(5):1721-7. PubMed ID: 17062236
[TBL] [Abstract][Full Text] [Related]
19. Improvement of cardiac stem cell sheet therapy for chronic ischemic injury by adding endothelial progenitor cell transplantation: analysis of layer-specific regional cardiac function.
Kamata S; Miyagawa S; Fukushima S; Nakatani S; Kawamoto A; Saito A; Harada A; Shimizu T; Daimon T; Okano T; Asahara T; Sawa Y
Cell Transplant; 2014; 23(10):1305-19. PubMed ID: 23562134
[TBL] [Abstract][Full Text] [Related]
20. [Stem cell therapy for cardiovascular diseases. Experiences in Düsseldorf].
Schannwell CM
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S274-9. PubMed ID: 19085806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
